Infectious diseases in the developing world - Preventative and Diagnostic advances (TechVision)

Infectious diseases in the developing world - Preventative and Diagnostic advances (TechVision)

Impact and assessment of novel diagnostic techniques to detect key infectious diseases

RELEASE DATE
30-Dec-2015
REGION
Asia Pacific
Research Code: D6BD-01-00-00-00
SKU: HC02411-AP-TR_16533

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02411-AP-TR_16533

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Infectious diseases that are caused by major pathogenic microorganisms such as viruses and bacteria pose severe public health challenges for individual governments. the International Health Regulations set up by the World Health Organization aims to cut down the risk of transfer of such infections across borders and limit the spread of disease. The research study on infectious diseases covers a range of diseases such as HIV, Ebola, Tuberculosis, Dengue, HPV, Malaria and HCV, which plague the developing regions currently. Additionally, the aim of this research service is to understand the existing diagnostics in the detection of these diseases as well as the diagnostic and preventative advances from key innovators that focus on regions of Africa, Asia and Latin America severely affected by infectious diseases. Apart from mapping the drivers and challenges that hold key to success of the diagnostics market for infectious diseases, the research study also details the healthcare structure, access and technology adoption in these three regions. Finally, the last three sections present the funding scenario, opportunity evaluation and IP landscape of key participants in the study.

Table of Contents

Research Process Methodology

Research Methodology (continued)

Key Findings

Overview

Human Immunodeficiency Virus (HIV)

Hepatitis C Virus (HCV)

Human Papillomavirus (HPV)

Tuberculosis

Ebola

Malaria

Dengue

Tuberculosis

Tuberculosis

Tuberculosis

Tuberculosis

Tuberculosis

HIV

HIV

HIV

HCV

HCV

HCV

Ebola

Ebola

Ebola

Ebola

Ebola

Dengue

Dengue

Dengue

Dengue

Malaria

Malaria

Malaria

HPV

HPV

HPV

HPVPreventative advances

Impact Mapping of Drivers and Challenges

Market Impact—Drivers Explained

Market Impact—Challenges Explained

Technology Adoption

Technology Adoption

Technology Adoption

Funding scenario

Funding scenario

Funding scenario

Funding scenario

Funding scenario

Funding scenario

Assessment of Partnerships

Assessment of Partnerships (continued)

Assessment of Partnerships (continued)

Assessment of Partnerships (continued)

Mergers and Acquisitions

Mergers & Acquisitions (continued)

HIV Diagnosis

HPV Diagnosis

HCV Diagnosis

Ebola Diagnosis

Tuberculosis Diagnosis

Malaria Diagnosis

Dengue Diagnosis

Influenza Diagnosis

Global Patents

Global Patents (continued)

Global Patents (continued)

Key contacts

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
Infectious diseases that are caused by major pathogenic microorganisms such as viruses and bacteria pose severe public health challenges for individual governments. the International Health Regulations set up by the World Health Organization aims to cut down the risk of transfer of such infections across borders and limit the spread of disease. The research study on infectious diseases covers a range of diseases such as HIV, Ebola, Tuberculosis, Dengue, HPV, Malaria and HCV, which plague the developing regions currently. Additionally, the aim of this research service is to understand the existing diagnostics in the detection of these diseases as well as the diagnostic and preventative advances from key innovators that focus on regions of Africa, Asia and Latin America severely affected by infectious diseases. Apart from mapping the drivers and challenges that hold key to success of the diagnostics market for infectious diseases, the research study also details the healthcare structure, access and technology adoption in these three regions. Finally, the last three sections present the funding scenario, opportunity evaluation and IP landscape of key participants in the study.
More Information
No Index No
Podcast No
Author Karan Verma
Industries Healthcare
WIP Number D6BD-01-00-00-00
Keyword 1 Infectious Diseases Therapeutics
Keyword 2 Therapeutic Area
Keyword 3 Infectious Disease Treatments
Is Prebook No